1.3100
+0.0300
+(2.34%)
At close: January 31 at 9:34:23 PM GMT+1
Breakdown
TTM
4/30/2024
4/30/2023
Operating Cash Flow
-6.2990
-6.2990
-0.2330
Financing Cash Flow
80.0000
80.0000
18.7500
End Cash Position
92.2180
92.2180
18.5170
Issuance of Capital Stock
80.0000
80.0000
18.7500
Free Cash Flow
-6.2990
-6.2990
-0.2330
4/30/2023 - 1/20/2025
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
OVIT OncoVista Innovative Therapies, Inc.
0.0002
0.00%
3G0.MU Altimmune Inc
6.67
+0.68%
BX2.F BioXcel Therapeutics, Inc.
0.3289
+10.00%
MOLN.SW Molecular Partners AG
4.8000
+2.78%
MOLN Molecular Partners AG
5.16
-3.55%
RLF.SW Relief Therapeutics Holding SA
3.7500
+0.54%
TLPPF Telix Pharmaceuticals Limited
17.99
0.00%
SRZN Surrozen, Inc.
11.60
-3.89%
TOVX Theriva Biologics, Inc.
1.2700
-0.78%
MLYS Mineralys Therapeutics, Inc.
10.30
+0.29%